Allows licensed pharmacists to prescribe FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen.

New York S02625 amends the public health and education laws to allow licensed pharmacists to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for treating opioid use disorder. This includes registering with the federal Drug Enforcement Administration and completing required training. The bill also mandates the establishment of a statewide protocol for pharmacist prescribing and requires reporting to the patient's primary health care practitioner.

Allows licensed pharmacists to prescribe FDA-approved medication assisted therapy for opioid use disorder under a non-patient-specific regimen.

New York S02625 amends the public health and education laws to allow licensed pharmacists to prescribe and order FDA-approved medication assisted therapy under a non-patient-specific regimen for treating opioid use disorder. This includes registering with the federal Drug Enforcement Administration and completing required training. The bill also mandates the establishment of a statewide protocol for pharmacist prescribing and requires reporting to the patient's primary health care practitioner.